Clinical Trial Results from Peerbridge Health Unveil Direct-from-ECG Sleep Apnea Detection Using COR Wearable Platform

Peerbridge Health has announced the successful completion and findings of its prospective, feasibility clinical trial, resulting in a statistically significant 91.2% predictive accuracy for the determination of apnea-hypopnea index (AHI) for diagnosing obstructive sleep apnea (OSA) while using the Peerbridge Cor, a patented 3-lead, 2-channel wireless continuous ECG wearable device that allows physicians the ability to address and assess sleep and heart health remotely.

Related Keywords

Texas ,United States ,Northwell ,American ,Americans ,Andrea Natale ,Chris Darland ,Nicholas Skipitaris ,American Academy Of Sleep Medicine ,David Medical Center ,Northwell Health ,Peerbridge Health ,American Heart Association ,Association For Sleep Clinicians ,Texas Cardiac Arrhythmia Institute At St ,Drug Administration ,Western Regional Director ,Cardiac Electrophysiology ,Peerbridge Cor ,Heart Failure ,Executive Medical Director ,Texas Cardiac Arrhythmia Institute ,Peerbridge Health President ,Rejection Fraction ,Trial Results ,Home Sleep Test ,Heart Association ,Sleep Medicine ,Sleep Clinicians ,